WallStSmart

Elevance Health Inc (ELV)vsProgyny Inc (PGNY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Elevance Health Inc generates 15352% more annual revenue ($199.13B vs $1.29B). PGNY leads profitability with a 4.5% profit margin vs 2.8%. ELV trades at a lower P/E of 11.5x. ELV earns a higher WallStSmart Score of 67/100 (B-).

ELV

Strong Buy

67

out of 100

Grade: B-

Growth: 7.3Profit: 5.0Value: 10.0Quality: 5.0
Piotroski: 3/9

PGNY

Hold

50

out of 100

Grade: D+

Growth: 7.3Profit: 6.0Value: 7.7Quality: 7.3
Piotroski: 5/9Altman Z: 4.94
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ELVUndervalued (+74.9%)

Margin of Safety

+74.9%

Fair Value

$1179.36

Current Price

$296.09

$883.27 discount

UndervaluedFair: $1179.36Overvalued
PGNYUndervalued (+16.6%)

Margin of Safety

+16.6%

Fair Value

$25.84

Current Price

$17.75

$8.09 discount

UndervaluedFair: $25.84Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ELV4 strengths · Avg: 9.3/10
P/E RatioValuation
11.5x10/10

Attractively priced relative to earnings

Price/BookValuation
1.5x10/10

Reasonable price relative to book value

Market CapQuality
$64.08B9/10

Large-cap with strong market position

EPS GrowthGrowth
36.3%8/10

Earnings expanding 36.3% YoY

PGNY3 strengths · Avg: 8.7/10
Altman Z-ScoreHealth
4.9410/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

EPS GrowthGrowth
20.6%8/10

Earnings expanding 20.6% YoY

Areas to Watch

ELV4 concerns · Avg: 2.8/10
Profit MarginProfitability
2.8%3/10

2.8% margin — thin

Operating MarginProfitability
1.5%3/10

Operating margin of 1.5%

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Free Cash FlowQuality
$-209.00M2/10

Negative free cash flow — burning cash

PGNY3 concerns · Avg: 3.3/10
P/E RatioValuation
27.8x4/10

Moderate valuation

Market CapQuality
$1.48B3/10

Smaller company, higher risk/reward

Profit MarginProfitability
4.5%3/10

4.5% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : ELV

The strongest argument for ELV centers on P/E Ratio, Price/Book, Market Cap. PEG of 1.17 suggests the stock is reasonably priced for its growth.

Bull Case : PGNY

The strongest argument for PGNY centers on Altman Z-Score, Price/Book, EPS Growth.

Bear Case : ELV

The primary concerns for ELV are Profit Margin, Operating Margin, Piotroski F-Score. Thin 2.8% margins leave little buffer for downturns.

Bear Case : PGNY

The primary concerns for PGNY are P/E Ratio, Market Cap, Profit Margin. Thin 4.5% margins leave little buffer for downturns.

Key Dynamics to Monitor

PGNY carries more volatility with a beta of 1.01 — expect wider price swings.

ELV is growing revenue faster at 9.5% — sustainability is the question.

PGNY generates stronger free cash flow (49M), providing more financial flexibility.

Monitor HEALTHCARE PLANS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ELV scores higher overall (67/100 vs 50/100). PGNY offers better value entry with a 16.6% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Elevance Health Inc

HEALTHCARE · HEALTHCARE PLANS · USA

Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.

Progyny Inc

HEALTHCARE · HEALTHCARE PLANS · USA

Progyny, Inc., a benefits management company, specializes in fertility benefits and family development solutions for employers in the United States. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?